Mankind Pharma Ltd. Conference Calls and Earnings Call Transcripts

08 Aug 2023

2559.10

0.62%

Earnings Call

Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the transcript of the Investor Conference Call for Q1FY24 held on Thursday, August 03, 2023.

pdf

Mankind Pharma Ltd.

03 Aug 2023

2559.10

0.62%

Earnings Call

Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and further to our intimation dated July 21, 2023 under subject 'Intimation of Investor Conference Call on Q1FY24 with Senior Management of Mankind Pharma Limited', the audio recording of the Performance and Business Update Call held today i.e. 03rd August 2023 is available on the website of the Company at https://www.mankindpharma.com/media/investor/kot1320230803148085-orignal-1691059985.mp3

pdf

Mankind Pharma Ltd.

03 Aug 2023, 03:56PM

2559.10

0.62%

Mankind Pharma Results Earnings Call for Q1FY24

Conference Call with Mankind Pharma Management and Analysts on Q1FY24 Performance and Outlook. Listen to the full earnings transcript.

audio

Mankind Pharma Ltd.

06 Jun 2023

2559.10

0.62%

Earnings Call

Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the transcript of the Performance and Business Update Call for Q4FY23 & FY23 held on Wednesday, 31st May 2023. The transcript is also available on the website of the Company at https://www.mankindpharma.com/media/investor/q4-fy23-transcript-1686050139.pdf

pdf

Mankind Pharma Ltd.

31 May 2023

2559.10

0.62%

Earnings Call

Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and further to our intimation dated 25th May 2023 under subject 'Intimation of Performance and Business Update Call on Q4FY23 & FY23 with Senior Management of Mankind Pharma Limited', the audio recording of the Performance and Business Update Call held today i.e. 31st May 2023 is available on the website of the Company at https://www.mankindpharma.com/media/investor/kot1320230531147437-1685528185.mp3

pdf

Mankind Pharma Ltd.

31 May 2023

2559.10

0.62%

Mankind Pharma Results Earnings Call for Q4FY23

Conference Call with Mankind Pharma Management and Analysts on Q4FY23 Performance and Outlook. Listen to the full earnings transcript.

audio

Mankind Pharma Ltd. Conference Calls and Earnings Call Transcripts